# Clinical Validation of HostDx Sepsis™ on NanoString; a Prospective Observational Validation Trial

> **NCT04414189** · — · COMPLETED · sponsor: **Inflammatix** · enrollment: 200 (actual)

## Conditions studied

- Sepsis

## Interventions

- **DIAGNOSTIC_TEST:** HostDx Sepsis

## Key facts

- **NCT ID:** NCT04414189
- **Lead sponsor:** Inflammatix
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-07
- **Primary completion:** 2021-07-21
- **Final completion:** 2021-10-19
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2021-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04414189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04414189, "Clinical Validation of HostDx Sepsis™ on NanoString; a Prospective Observational Validation Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04414189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*